BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidhammer H, Erli F, Guerrieri E, Spetea M. Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities. Molecules 2020;25:E5092. [PMID: 33147885 DOI: 10.3390/molecules25215092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Stefanucci A, Minosi P, Pieretti S, Tanguturi P, Molnar G, Scioli G, Marinaccio L, Della Valle A, Streicher JM, Mollica A. Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan Ligands. ACS Chem Neurosci 2023. [PMID: 36651179 DOI: 10.1021/acschemneuro.3c00005] [Reference Citation Analysis]
2 Santino F, Gentilucci L. Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects. Molecules 2023;28. [PMID: 36615540 DOI: 10.3390/molecules28010346] [Reference Citation Analysis]
3 Janković SM, Đešević M. Advancements in neuroactive peptides in seizures. Expert Review of Neurotherapeutics. [DOI: 10.1080/14737175.2022.2031983] [Reference Citation Analysis]
4 Bodnar RJ. Endogenous opiates and behavior: 2020. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170752] [Reference Citation Analysis]
5 Zhou Q, Zhang Z, Long S, Li W, Wang B, Liang N. Opioids in cancer: The κ‑opioid receptor (Review). Mol Med Rep 2022;25:44. [PMID: 34878160 DOI: 10.3892/mmr.2021.12560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Spetea M, Schmidhammer H. Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery. Molecules 2020;25:5658. [DOI: 10.3390/molecules25235658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]